Pharmaceutical Technology

MAY 31, 2023

The university and Pharos have drawn up a memorandum of understanding (MoU) to use AI technology to identify potential compounds for the rapid development of treatments. The MoU allows Pharos to collaborate with the university’s researchers and gives access to its advanced drug discovery infrastructure.

Compounding 59

Compounding Data Entry Drug Development Pharmaceutical Companies 59

European Pharmaceutical Review

JULY 25, 2023

A compound annual growth rate (CAGR) growth of 5.9 percent during the forecast period from 2023 to 2032 is predicted. Complex compounds offer targeted, effective medicines and typically outperform small molecule APIs. billion by 2032. This is a rise from $162.8 billion in 2022.

Compounding 97

Compounding Generic Medicine Drug Development Diabetes 97

European Pharmaceutical Review

AUGUST 7, 2023

Credit: 2023 H. Many compounds can be synthesised by continuous-flow manufacturing, commented Ishitani. “By By adopting this method, we believe that we can contribute to a stable drug supply, respond to rare diseases and disasters, and aid new drug development.” From there flowed the cefazolin.

Compounding 97

Compounding Hospitals Drug Development 97

European Pharmaceutical Review

DECEMBER 5, 2022

Pluvicto is an intravenous radioligand therapy that combines a ligand, a targeting compound with lutetium-177, a therapeutic radionuclide. Regulatory approval will be discussed with the US Food and Drug Administration (FDA) in 2023. The PSMAfore study. Pluvicto for PSMA–positive metastatic castration-resistant prostate cancer.

Chemotherapy 105

Chemotherapy Compounding Labelling Drug Development 105

European Pharmaceutical Review

JUNE 15, 2023

According to a report by Future Market Insights, the small molecule innovator contract development and manufacturing organisation (CDMO) market is projected to value $48.09 billion in 2023 and $89.43 Sales in the small molecule innovator CDMO market is expected to grow at a compound annual growth rate (CAGR) of 6.4

Compounding 52

Compounding Drug Development 52

pharmaphorum

NOVEMBER 24, 2022

Submitted proposals must be received by 15 February 2023. Following a two-stage selection process, the successful five projects will be announced in July 2023 (with a maximum award of £2.5 billion after selling a portion of its royalty interest in Merck & Co’s blockbuster cancer drug Keytruda to a pension fund.

Hospitals 59

Hospitals Compounding Drug Development 59

European Pharmaceutical Review

JULY 5, 2023

Compound annual growth rate (CAGR) for the market is anticipated to reach 8.4 percent between 2023 and 2033. Article: International regulation: the importance of quality assurance in drug development … What can a clinical research organisation (CRO) provide?

Compounding 52

Compounding Drug Development 52

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 Anna has a medical degree and a postgraduate degree in healthcare management and is an expert in all stages of drug development. 2023; 11(5):1434.

Vaccines 98

Vaccines Immunity Immunization Compounding 98

pharmaphorum

DECEMBER 5, 2022

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

Chemotherapy 59

Chemotherapy Compounding Labelling Drug Development 59

Pharmaceutical Technology

DECEMBER 16, 2022

MMV and Novartis have worked on the upcoming Phase III study’s plans over the course of this year and plan to start the study in 2023, says MMV CEO David Reddy. The post 2022 in review: Drug development milestones for tropical diseases appeared first on Pharmaceutical Technology.

Drug Development 105

Drug Development Vaccines Clinical Pharmacology Compounding 105

Pharmaceutical Technology

SEPTEMBER 12, 2022

Development bogged down by complexity. While there is an unmet need, drug development remains slow due to neurological complexity. “We Other approaches include Neuronasal’s through-the-nose drug based on N-acetylcysteine (NAC). The mechanism is complicated. Even convincing potential investors is challenging, says Baudry.

Drug Development 94

Drug Development Compounding 94

European Pharmaceutical Review

JULY 4, 2024

4,6 Five patent issues that European biosimilar developers should consider before entering the US market Quality control of the botanical drug substances was one of the critical factors that led to barricades during the development of Veregen and Mytesi. BMB Reports. 2017;50(3):111–6. Premier Consulting [Internet].

Drug Development 103

Drug Development Biosimilars Documentation Compounding 103

Express Pharma

JULY 10, 2024

With advancements in biotechnology, robust scientific capabilities, cost-effective manufacturing processes, a large workforce and a shift towards more complex biologic drugs, India is at the cusp of a huge opportunity to emerge as a leader in biopharma.

Vaccines 75

Vaccines Drug Development Process Improvement Biosimilars 75

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Compounding Drug Development 132

PharmaShots

APRIL 3, 2023

Shots: The first quarter of 2023 highlights major acquisitions in the pharma and biotech industry along with multiple approvals. Date - Jan 04, 2023 Product – N/A The acquisition is completed from a shareholder group led by Nordic Capital, in an all-cash transaction valued at $2.8B per ADS up front & CVR of ~$2.50

Biosimilars 40

Biosimilars Diabetes Compounding Hospitals 40

Express Pharma

JUNE 11, 2024

With the evolving landscape of drug development and innovations, several institutes are serving as catalysts by partnering with pharmaceutical companies to drive progress at various stages of research and development. The number of clinical trials has significantly increased from 31 trials in 2019 to 79 trials in 2023.

Pharmaceutical Companies 88

Pharmaceutical Companies Pharmaceutical Companies Drug Development Compounding 88

European Pharmaceutical Review

FEBRUARY 14, 2024

As previously highlighted batch-to-batch variability in potency is expected, however, the compounding effect of method related variability in quantification makes root cause analysis even more difficult when trying to identify those parameters/conditions for process establishment/scale up. Gullifa G, Risoluti R, Mazzoni C, et al.

Dosage 97

Dosage Packaging Compounding Labelling 97

European Pharmaceutical Review

JULY 14, 2023

However, extensive capital investment and complex infrastructure is necessary for carrying out in-house filling of biologics and small molecules, which can be a challenge for drug developers with limited finances and capacity constraints. For example, vials currently have the largest share, at 67 percent.

Packaging 98

Packaging Compounding Drug Development 98

Express Pharma

SEPTEMBER 24, 2023

The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR). This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA.

Drug Development 52

Drug Development Compounding 52

ID Stewardship

JUNE 6, 2023

BCPS, BCIDP Article Posted 7 June 2023 With the exception of the questions in bold, this entire text was written by ChatGPT. Industry pharmacists can utilize AI to identify potential drug targets, optimize lead compounds, and predict drug efficacy, ultimately expediting the development of new therapies.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling Hospitals Medication Dispensing 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The number of requirements in the revised Annex 1 has been significantly expanded from the original 2008 version and will come into force on 25 August 2023.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52